Trial
NCT01222572
Stereotactic Boost for Locally Advanced Non-Small Cell Lung Cancer
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Brigham and Women's Hospital
Condition
Non-small Cell Lung Cancer
Intervention
Stereotactic boost
Why stopped
Slow accrual due to restrictive eligibility criteria
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2015-06-04